{"data":{"id":"us-in/ic-16-42-23-2","jurisdiction":"us-in","citation":"IC 16-42-23-2","heading":"Disciplinary action against attending physician","body":"Sec. 2. A physician may not be subjected to disciplinary action by the medical licensing board of Indiana for prescribing or administering amygdalin (laetrile) to a patient under the physician's care as an adjunct to recognized, customary, or accepted modes of therapy in the treatment of a malignancy, a disease, an illness, or a physical condition if the patient has signed the written informed request as set forth in section 5 of this chapter.","path":["TITLE 16. HEALTH","ARTICLE 42. REGULATION OF FOOD, DRUGS, AND COSMETICS","Chapter 23. Drugs: Use of Amygdalin (Laetrile)"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-42-23-2","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"115d39e973797ea35994a256ab5f8c24570565bd808a866d295b1984e8186c10","source_id":"us-in","stale":false,"prev":"us-in/ic-16-42-23-1","next":"us-in/ic-16-42-23-3"},"notice":"GroundRules: Original legal text. Not legal advice."}